chevron_leftBack
As of 24 April 2025, Fresenius SE & Co. KGaA has a market cap of $25.2B USD, ranking #760 globally and #31 in Germany. It ranks #66 in the Healthcare sector, and #3 in the Medical Care Facilities industry.
Key Stats
Market Cap
$25.2BUSD
22.24B EUR
Enterprise Value
$38.84BUSD
34.27B EUR
Revenue (TTM)
$24.74BUSD
21.83B EUR
EBITDA (TTM)
$2.93BUSD
2.59B EUR
Net Income (TTM)
$533.76MUSD
471.0M EUR
EBITDA Margin
12%
Profit Margin
2.2%
PE Ratio
21.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Michael Sen
open_in_new
Employees
176,486
Founded
1912
Website
fresenius.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 0.9% | -0.5% | 9.9% | 17% | 44% |
Upcoming Earnings
Earnings Date
Wed, May 7
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
FRE
Fresenius SE & Co KGaA
ISIN: DE0005785604
Shares Out.:
Shares Outstanding:
563.237M1
Shares Float:
411.32M2
|
39.48 EUR | |
|
0OO9
Fresenius SE & Co KGaA
ISIN: DE0005785604
|
39.01 EUR | |
|
1FRE
Fresenius SE & Co KGaA
ISIN: DE0005785604
|
39.39 EUR | |
|
FRE
Fresenius SE & Co KGaA
ISIN: DE0005785604
|
39.22 EUR | |
|
FSNUF
Fresenius SE & Co KGaA
ISIN: DE0005785604
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
37.73 USD | |
|
FSNUY
Fresenius SE & Co KGaA ADR
ISIN: US35804M1053
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.19 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
